Invention Grant
- Patent Title: Formulations of histone deacetylase inhibitor and uses therof
- Patent Title (中): 组蛋白脱乙酰酶抑制剂的制剂，并使用该方法
-
Application No.: US14069233Application Date: 2013-10-31
-
Publication No.: US09403032B2Publication Date: 2016-08-02
- Inventor: David J. Loury , Joseph J. Buggy , Tarak D. Mody , Erik J. Verner , Norbert Purro , Sriram Balasubramanian
- Applicant: Pharmacyclics LLC
- Applicant Address: US CA Sunnyvale
- Assignee: Pharmacyclics LLC
- Current Assignee: Pharmacyclics LLC
- Current Assignee Address: US CA Sunnyvale
- Agency: Foley Hoag LLP
- Main IPC: A61K31/166
- IPC: A61K31/166 ; A61N5/10 ; A61K45/00 ; A61K9/20 ; A61K9/28 ; A61K9/48 ; A61K9/50 ; A61K31/343 ; A61K31/35 ; A61K31/381 ; A61K31/40 ; A61K31/47 ; A61K31/497 ; A61K31/69 ; A61K47/02 ; A61K47/12 ; A61K31/4184 ; A61K31/573 ; A61K31/704 ; A61K45/06 ; C07D307/85 ; A61K38/05
Abstract:
Dosing regimens, methods of treatment, controlled release formulations, and combination therapies that include an HDAC inhibitor, or a pharmaceutically acceptable salt thereof, are described.
Public/Granted literature
- US20140057862A1 FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEROF Public/Granted day:2014-02-27
Information query
